Michael M. Hoffmann
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 35
- Hormonal Regulation and Hypertension 9
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 8
- Geriatrics and Gerontology top 2%
- Surgery top 2%
- Lipoproteins and Cardiovascular Health 40
- Adrenal and Paraganglionic Tumors 7
- Nephrology top 5%
-
- Adipokines, Inflammation, and Metabolic Diseases 13
-
- Lipid metabolism and disorders 13
-
- Atherosclerosis and Cardiovascular Diseases 8
- Co-authors
- Winfried MärzBernhard R. WinkelmannHeinrich WielandKarl WinklerBernhard O. BoehmJohanna WeißHubert ScharnaglWalter E. Haefeli
- Journals
- Atherosclerosis (14 papers)The Journal of Clinical Endocrinology & Metabolism (11 papers)European Heart Journal (7 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael M. Hoffmann
141 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 888
- Cancer Research 605
- Geriatrics and Gerontology 142
- Surgery 1.4k
- Nephrology 198
Countries citing papers authored by Michael M. Hoffmann
This map shows the geographic impact of Michael M. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Hoffmann more than expected).
Fields of papers citing papers by Michael M. Hoffmann
This network shows the impact of papers produced by Michael M. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Hoffmann. The network helps show where Michael M. Hoffmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael M. Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | Endokrine Modulatoren Endocrine disruptors | 2017 | 3 |
| 3 | 2015 | 11 | |
| 4 | 2012 | 47 | |
| 5 | Soluble Interleukin 2 Receptor, Angiotensin Converting Enzyme, And Neopterin in Screening Ocular Sarcoidosis And Monitoring Disease Activity | 2012 | 2 |
| 6 | 2012 | 18 | |
| 7 | 2011 | 22 | |
| 8 | 2010 | 74 | |
| 9 | 2010 | 78 | |
| 10 | 2008 | 70 | |
| 11 | 2005 | 81 | |
| 12 | 2004 | 100 | |
| 13 | 2003 | 27 | |
| 14 | 2003 | 9 | |
| 15 | 2002 | 20 | |
| 16 | 2001 | 16 | |
| 17 | 2000 | 13 | |
| 18 | 1999 | 50 | |
| 19 | 1999 | 99 | |
| 20 | 1998 | 20 |
About Michael M. Hoffmann
Michael M. Hoffmann is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, having authored 143 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (40 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (35 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers), Lipid metabolism and disorders (13 papers), Hormonal Regulation and Hypertension (9 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Cancer, Lipids, and Metabolism (8 papers) and Adrenal and Paraganglionic Tumors (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (888 citations), Cancer Research (605 citations) and Geriatrics and Gerontology (142 citations). Michael M. Hoffmann has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Winfried März, Bernhard R. Winkelmann, Heinrich Wieland, Karl Winkler, Bernhard O. Boehm, Johanna Weiß, Hubert Scharnagl, Walter E. Haefeli, Markus Nauck and I. Friedrich. Their work appears in journals such as Atherosclerosis, The Journal of Clinical Endocrinology & Metabolism, European Heart Journal, Clinical Chemistry and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.